Status:
COMPLETED
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Childhood Cancer Survivors Treated With Abdominal Radiation
Eligibility:
All Genders
Brief Summary
The purpose of this study is to better understand the risk factors and causes of diabetes in people who received radiation to the abdomen as children. The investigators hope this information will allo...
Eligibility Criteria
Inclusion
- Diagnosis of childhood cancer between 0-21 years of age
- Prior treatment with abdominal radiation at MSKCC
- Two or more years from completion of therapy
- Records of cancer diagnosis and treatment (including radiation records) available
Exclusion
- Known diagnosis of diabetes
- Previous treatment with any radiation impacting the brain (cranial radiation, craniospinal radiation, total body irradiation)
- Neurocognitive deficits that impair ability to give informed consent or assent
- Patients predicted to have difficult intravenous access, who will likely require multiple venipuncture attempts
Key Trial Info
Start Date :
September 22 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT02248779
Start Date
September 22 2014
End Date
October 9 2019
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065